GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited$2,194.55
Jun 09, 2026
Market cap
$366.61B
52w range
—
P / E
—
EPS · FY 2026
$61.15
Volume
—
Revenue · FY 2026
$38.22B
Explain this page
Arphra AIPlain-English read on GlaxoSmithKline Pharmaceuticals Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,360.84
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Communication Services+1.98%
- Energy+1.34%
- Technology+0.77%
- Financial Services+0.75%
- Consumer Defensive+0.61%
- Real Estate+0.22%
- Consumer Cyclical-0.61%
- Healthcare-0.67%
- Basic Materials-0.81%
- Utilities-1.73%
- Industrials-2.26%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General+0.22%
- Engineering & Construction-4.95%
- Biotechnology+4.64%
- Agricultural - Machinery-3.98%
- Renewable Utilities-3.24%
- Independent Power Producers-3.23%
- Electrical Equipment & Parts-2.99%
- Internet Content & Information+2.98%
- Solar-2.84%
- Auto - Parts-2.59%
- Oil & Gas Drilling+2.55%
- Construction-2.42%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for GLAXO.BO.
Peers
No peer list available for GLAXO.BO.
Total assets
$43.24B
Total debt
$332.7M
Cash & equiv
$13.91B
Operating CF
$10.22B
Free cash flow
$9.67B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $38.22B | $12.43B | $10.36B | $61.15 | +27.11% |